CoChat

Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial

Open access
Jones, Caitlin M P, Day, Richard O, Koes, Bart W, Latimer, Jane, Maher, Chris G, McLachlan, Andrew J, Billot, Laurent, Shan, Sana, Lin, Chung-Wei Christine, McLachlan, Hanan, Webb, Melissa, Hamilton, Melanie, Ahedi, Harbeer, Barber, Angie, Mak, Wendy, Mathieson, Stephanie, Petrova, Veronika, Bompoint, Severine, Shan, Sana, Murnion, Bridin, Buckley, Nicholas, Demirkol, Apo, Wrigley, Paul, Needs, Christopher, Brooks, Louise, Cantori, Samuel, Preisz, Paul, Aitken, James, Allan, Sujata, Burke, Michael, Cameron, Greg, Cepeda, Francisco Javier Valencia, Davis, Christopher, Dullur, Jayasree, Emmanuel, Joseph, Errey, Catherine, Fieuw-Makaroff, Sabine, Gaudry, Adam, Genua, L, Longhurst, Ian, McCroary, Kenneth, Merhi, Diana, Nguyen, Tanya, Obayd, Zahra Rassoly, Penm, Michelle, Pobbathi, Sharan, Poh, William S, Schnitzler, Paul, Shahnaz, Sabiha, Tan, Ven, Tang, Danny, Tan, Brian, Thu, Win Kyaw, Triantopolous, Thrasivolous, Venkatesan, Ramana, Wong, Wicky Chun Fai, Yang, Shu Ching · 2023 · The Lancet
Cited by 164

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

BACKGROUND Opioid analgesics are commonly used for acute low back pain and neck pain, but supporting efficacy data are scarce. We aimed to investigate the efficacy and safety of a judicious short course of an opioid analgesic for acute low back pain and neck pain. METHODS OPAL was a triple-blinded, placebo-controlled randomised trial that recruited adults (aged ≥18 years) presenting to one of 157 primary care or emergency department sites in Sydney, NSW, Australia, with 12 weeks or less of low back or neck pain (or both) of at least moderate pain severity. Participants were randomly assigned (1:1) using statistician-generated randomly permuted blocks to guideline-recommended care plus an opioid (oxycodone-naloxone, up to 20 mg oxycodone per day orally) or guideline-recommended care and an identical placebo, for up to 6 weeks. The primary outcome was pain severity at 6 weeks measured with the pain severity subscale of the Brief Pain Inventory (10-point scale), analysed in all eligible participants who provided at least one post-randomisation pain score, by use of a repeated measures linear mixed model. Safety was analysed in all randomly assigned eligible participants. The trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12615000775516). FINDINGS Between Feb 29, 2016, and March 10, 2022, 347 participants were recruited (174 to the opioid group and 173 to the placebo group). 170 (49%) of 346 participants were female and 176 (51%) were male. 33 (19%) of 174 participants in the opioid group and 25 (15%) of 172 in the placebo group had discontinued from the trial by week 6, due to loss to follow-up and participant withdrawals. 151 participants in the opioid group and 159 in the placebo group were included in the primary analysis. Mean pain score at 6 weeks was 2·78 (SE 0·20) in the opioid group versus 2·25 (0·19) in the placebo group (adjusted mean difference 0·53, 95% CI -0·00 to 1·07, p=0·051). 61 (35%) of 174 participants in the opioid group reported at least one adverse event versus 51 (30%) of 172 in the placebo group (p=0·30), but more people in the opioid group reported opioid-related adverse events (eg, 13 [7·5%] of 174 participants in the opioid group reported constipation vs six [3·5%] of 173 in the placebo group). INTERPRETATION Opioids should not be recommended for acute non-specific low back pain or neck pain given that we found no significant difference in pain severity compared with placebo. This finding calls for a change in the frequent use of opioids for these conditions. FUNDING National Health and Medical Research Council, University of Sydney Faculty of Medicine and Health, and SafeWork SA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(23)00404-x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 164

Metadata

Authors
Jones, C. M. P., Day, R. O., Koes, B. W., Latimer, J., Maher, C. G., McLachlan, A. J., Billot, L., Shan, S., Lin, C.-W. C., McLachlan, H., Webb, M., Hamilton, M., Ahedi, H., Barber, A., Mak, W., Mathieson, S., Petrova, V., Bompoint, S., Shan, S., Murnion, B., Buckley, N., Demirkol, A., Wrigley, P., Needs, C., Brooks, L., Cantori, S., Preisz, P., Aitken, J., Allan, S., Burke, M., Cameron, G., Cepeda, F. J. V., Davis, C., Dullur, J., Emmanuel, J., Errey, C., Fieuw-Makaroff, S., Gaudry, A., Genua, L., Longhurst, I., McCroary, K., Merhi, D., Nguyen, T., Obayd, Z. R., Penm, M., Pobbathi, S., Poh, W. S., Schnitzler, P., Shahnaz, S., Tan, V., Tang, D., Tan, B., Thu, W. K., Triantopolous, T., Venkatesan, R., Wong, W. C. F., & Yang, S. C.
Venue
The Lancet
Publisher
Elsevier BV
Published
2023-07
Volume
402
Issue
10398
Pages
304-312
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4382364567
Cited by
164
References
5
FWCI
37.77
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(23)00404-x
The paper
Jones, C. M. P., Day, R. O., Koes, B. W., Latimer, J., Maher, C. G., McLachlan, A. J., Billot, L., Shan, S., Lin, C.-W. C., McLachlan, H., Webb, M., Hamilton, M., Ahedi, H., Barber, A., Mak, W., Mathieson, S., Petrova, V., Bompoint, S., Shan, S., . . . Yang, S. C. (2023). Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(23)00404-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.